TORONTO, March 06, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable ...

Phosphaturic mesenchymal tumor (PMT) is an extremely rare neoplasm that causes tumor-induced osteomalacia (TIO) in most affected patients, usually through the production of fibroblast growth factor 23 ...

The clinical and radiographic impression was a lesion consistent with osteoid osteoma. The patient subsequently had surgical excision of the nidus. By an anterior approach, the base of the ...